Check out the latest news and insights from DrugDev

Join Mike Snape (CEO, AMO Pharma) and Donna Mackey (Senior Director of Clinical Operations, Alnylam) as they explore how to overcome the challenges of rare disease clinical trials – including trial design, patient recruitment and retention, and site support. Moderated by Ibs Mahmood (CEO, DrugDev) and Kris Sarajian (VP of Marketing, DrugDev)